EGFR-targeted therapy is used in the treatment of head and neck cancer via targeting the pathways involved in tumor growth, angiogenesis, metastasis and invasion (36), for example, the EGFR inhibitor, gefitinib, has been used in clinical practice in the treatment of head and neck squamous cell carcinoma (37). This evidence concerns the gene EGFR and neoplasm.